Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health

December 2025 in “ Zenodo (CERN European Organization for Nuclear Research) ”

Nair, Varun S.

New to Finasteride? There is a guide in the encyclopedia. Read the guide →

Post-Finasteride Syndrome finasteride Post-SSRI Sexual Dysfunction pharmacovigilance drug safety adverse effects Propecia SSRIs

Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

Studysummary This policy brief highlights that post-drug syndromes remain under-recognized in pharmacovigilance, leading to inadequate risk assessments and patient care. It identifies systemic failures in current frameworks and recommends actions to improve long-term drug safety monitoring and education, affecting public health outcomes significantly.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on zenodo.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health

December 2025 in “Zenodo (CERN European Organization for Nuclear Research)”

This policy brief reports that post-drug syndromes like Post-Finasteride Syndrome are largely overlooked in current pharmacovigilance systems, which prioritize acute drug reactions, resulting in inadequate recognition and management of persistent medication-induced conditions.

research Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health

December 2025 in “Zenodo (CERN European Organization for Nuclear Research)”

This policy brief found that post-drug syndromes are under-recognized in current pharmacovigilance systems, leading to inadequate risk assessments and prolonged patient harm from persistent drug-induced conditions.

Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction: Two Clinically Similar Conditions

research POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE

November 2023 in “Frontiers in Neuroendocrinology”

This study suggests that post-finasteride syndrome and post-SSRI sexual dysfunction share potential etiopathogenetic mechanisms involving brain modulators, neurotransmitters, and gut microbiota, although more research is needed to understand these conditions fully.

research Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

40 citations , April 2018 in “Endocrine”

This review discusses post-SSRI sexual dysfunction and post-finasteride syndrome, highlighting unknowns about their true incidence and underlying causes, and reports no new clinical results.

research Post-Finasteride Syndrome: About 2 Cases and Review of the Literature

2 citations , January 2016 in “Andrology”

This case report study presents two instances of post-finasteride syndrome, highlighting the persistence of sexual adverse effects despite discontinuation of the drug, and underscores the need for increased awareness and understanding of this condition.